Supreme PLC Reports Record FY25 Results with Strategic Acquisitions Driving Growth
Record FY25: Supreme PLC hits £231.1m revenue & £40.5m EBITDA. Strategic buys of Typhoo Tea & Clearly Drinks drive diversification & growth. Analysis inside.
This article covers information on Supreme PLC.
LON:SUPRecord Results Fueled by Savvy M&A Moves
Supreme PLC’s latest financials tell a compelling story of strategic reinvention. While a 6% jump in Adjusted EBITDA to £40.5m and 4% revenue growth to £231.1m are impressive on their own, the real narrative lies in how they’ve navigated regulatory headwinds and diversified their portfolio. The acquisitions of Typhoo Tea and Clearly Drinks weren’t just box-ticking exercises – they’ve fundamentally reshaped the group’s earnings profile, adding £40m of annualised non-vape revenue almost overnight.
The Financial Engine Room
Let’s crack open the headline numbers:
- Margin Magic: Gross profit surged 16% to £73.7m, with margins climbing 300bps to 32%. This isn’t luck – it’s the result of bringing manufacturing in-house (Clearly Drinks’ 40% margins are a prime example) and ruthless operational efficiency.
- Cash Conundrum? Don’t let the 90% drop in adjusted net cash (£1.2m) spook you. This reflects £25.6m deployed in acquisitions – strategic capital allocation rather than distress. Crucially, operating cash flow remained robust at £25.1m.
- Dividend Delight: Shareholders get a 10% dividend hike to 5.2p per share. That’s not just generosity; it signals board confidence in sustainable cash generation.
Acquisitions: The Growth Accelerant
Supreme’s M&A playbook deserves study. They’re not chasing vanity projects – they’re hunting neglected assets with turnaround potential, leveraging their distribution muscle:
Typhoo Tea: Brewing a Comeback
Snapped up for just £10.2m from administration, this iconic brand had been mismanaged into £4.6m losses. Supreme’s already stabilised it, achieving £6.1m revenue and positive EBITDA contribution within four months. The plan? Reignite mainstream distribution, bring manufacturing back in-house, and exploit cross-selling across their 10,000+ retail outlets.
Clearly Drinks: Manufacturing Muscle
The £15.6m acquisition wasn’t just about brands – it was about capabilities. That 150,000 sq ft automated facility is a platform for new product development (think protein-infused wellness drinks). Crucially, they’ve already secured listings for Clearly’s brands with major existing clients – synergy in action.
Division Deep Dive: Navigating Choppy Waters
Vaping: Pivot, Don’t Panic
Yes, the UK disposable vape ban clipped revenues (£54.1m vs £70.7m). But look deeper: non-disposable vape sales grew 8%, and margins expanded. Supreme saw this coming, managed stock brilliantly (avoiding nasty write-downs), and is now a government advisor on vaping taxation. Their pod and rechargeable transition? Executed with military precision.
Drinks & Wellness: The New Powerhouse
Revenue doubled to £48.8m. Sci-MX (acquired for £1.4m in FY22, now delivering £10m revenue) exemplifies Supreme’s brand revival magic. Combining this with Typhoo and Clearly Drinks creates a formidable category – expect serious cross-selling fireworks in FY26.
Electricals: Steady Eddy
A 6% revenue dip to £53.4m reflects a tough market, but it remains a reliable cash generator. Supreme’s outperforming the sector decline – a testament to their retailer relationships and logistical edge.
Outlook: Confidence Brewing
Management’s guidance is refreshingly clear: FY26 trading in line with consensus (£236m revenue, £36.5m EBITDA). The focus is clear:
- Organic Growth: Cross-selling Typhoo/Sci-MX/Clearly Drinks across their vast network is low-hanging fruit.
- Manufacturing Leverage: Maximising ROI on those new facilities.
- Selective M&A: Their war chest is rebuilding, and the pipeline is active. Expect more earnings-enhancing deals.
The Verdict: More Than Just Vapes
Supreme’s transformation is palpable. They’ve deftly handled a regulatory earthquake in vaping while simultaneously building a diversified, brand-led FMCG platform with serious manufacturing clout. The record results are impressive, but the strategic repositioning is what truly excites. Trading on a PER just north of 12x? For a business with this growth trajectory and M&A optionality, that feels like a potential mispricing. One to watch closely as the drinks and wellness integration plays out.
Chadha and team are playing chess, not checkers. Their next move should be fascinating.
Related
Keep reading
Investing
Brave Bison Raises System1 Offer to £47.5 Million as Delisting Stakes Grow
Brave Bison's fourth System1 offer values the target at £47.5 million, but the deal remains conditional on securing majority support.
JoshuaSeptember 14, 2026
Investing
Keras Resources pivots to Namibian copper with US phosphate sale and £1.7 million raise
Keras Resources is reshaping itself around Namibian copper, backed by a US phosphate disposal, royalties and a £1.7 million raise.
JoshuaSeptember 14, 2026
Investing
Empyrean Energy adds Austrian gas exposure as equity fundraising looms
Empyrean Energy has agreed an Austrian gas farm-in, but shareholders face exploration risk, a trading halt and likely equity dilution.
JoshuaSeptember 14, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.